Exton, Pennsylvania – November 04, 2026 -- West Pharmaceutical Services, Inc. (NYSE: WST), which generated $3.07 billion in net sales in fiscal year 2025, will present at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 8:00 a.m. GMT.
West delivers over 41 billion components and devices a year from 50 sites
The injectable drug administration supplier employs more than 10,000 people across 50 sites, including 26 manufacturing facilities worldwide. Its output of over 41 billion components and devices annually serves both established and emerging drug developers, according to the company.
West is headquartered in Exton and is a member of the Standard & Poor's 500 index.
Investors can follow the session through a live audio webcast with a 90-day replay
The live audio webcast will be available in the Investors section of West's website. A replay will remain accessible for approximately 90 days after the event.